Light resistance training with pressure cuffs may help older adults with muscle loss walk faster and stand up from a chair more easily, similar to heavy weight training.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether LRT-BFR consistently improves SPPB and gait speed comparably to CRT in older adults with sarcopenia across diverse settings and protocols.
A systematic review and meta-analysis of all RCTs comparing LRT-BFR (20–30% 1RM, 50% LOP) to CRT (≥60% 1RM) in adults ≥65 with AWGS-defined sarcopenia, measuring SPPB total score and 6-meter walk speed as primary outcomes over ≥12 weeks. Minimum 12 trials, 400+ participants.
Whether LRT-BFR produces equivalent improvements in SPPB and gait speed compared to CRT in older adults with sarcopenia under controlled conditions.
A double-blind RCT with 200+ participants aged 65–85 with sarcopenia, randomized to LRT-BFR (3x/week, 20–30% 1RM, 50% LOP) or CRT (3x/week, 60–75% 1RM) for 24 weeks, with SPPB score and 6-meter walk speed as primary endpoints.
Whether LRT-BFR use is associated with slower decline in SPPB and gait speed over 3–5 years in older adults with sarcopenia.
A prospective cohort study following 500 older adults with sarcopenia for 5 years, comparing those who regularly perform LRT-BFR (≥12 weeks/year) to non-users, measuring annual changes in SPPB and gait speed.
Whether prior LRT-BFR use is associated with higher SPPB scores and faster gait speed in older adults with sarcopenia compared to non-users.
A case-control study comparing 100 older adults with low SPPB score (≤6) and slow gait speed (<0.8 m/s) to 100 matched controls, retrospectively assessing prior LRT-BFR exposure over the past 2 years.
Whether older adults currently using LRT-BFR have higher SPPB scores and faster gait speed than those not using it at a single time point.
A cross-sectional survey of 1000 community-dwelling adults aged 65+ with sarcopenia, measuring current LRT-BFR use and SPPB/gait speed in a single assessment, adjusting for age, sex, and comorbidities.